Posts

Showing posts with the label Cell Lysis & Disruption Market Revenue

Cell Lysis & Disruption Market Segment Analysis By Technique, Product, Cell Type, Application, End Use, Region And Forecast Till 2028

Image
  San Francisco, 10 Aug 2021:   The Report  Cell Lysis & Disruption Market  Size, Share & Trends Analysis Report By Application (Protein Isolation, Downstream Processing), By Cell Type, By Technique, By Product, By End Use, And Segment Forecasts, 2021 - 2028 The global cell lysis & disruption market size is expected to reach USD 8.37 billion by 2028, registering a CAGR of 9.35% over the forecast period, according to a new report by Grand View Research, Inc. The anticipated revenue growth is attributed to accelerating the adoption of cell lysis and disruption methods during downstream processing to manufacture bio-therapeutics and other animal-based recombinant products. Technological developments in procedures involved in releasing cellular organelles have paved the way for the higher adoption of cell disruption methods. As retrieval and purification of biopharmaceuticals involve cell disruption, a rise in demand for biopharma would lead to the subsequent growth of the mark

Cell Lysis & Disruption Market Accounted At USD 5.65 Billion By 2025 : Grand View Research Inc.

San Francisco, 9 August 2019:   The Report   Cell Lysis & Disruption Market   Size, Share & Trends Analysis Report By Cell Type, By Product, By Technique (Physical Disruption, Reagent-based), By Application, By End Use, By Region, And Segment Forecasts, 2019 – 2025 The global cell lysis & disruption market size is expected to reach USD 5.65 billion by 2025 registering a CAGR of 8.31%, according to a new report by Grand View Research, Inc. Demand for cell lysis & disruption is driven by the immense growth of the biotechnology sector globally. This is majorly due to the high adoption of biotech processes in the pharmaceutical, agricultural, and bio-services industries. Technological developments in procedures involved to release cellular organelles have paved the way for higher adoption of cell disruption methods. As retrieval and purification of biopharmaceuticals involve cell disruption, a rise in demand for biopharma would lead to the subsequent growth of the mark